﻿{"id":1560780,"date":"2021-01-23T00:05:41","date_gmt":"2021-01-22T21:05:41","guid":{"rendered":"http:\/\/www.erzurumflas.com\/medical-parkta-diyabet-konusuldu\/"},"modified":"2021-01-23T00:05:48","modified_gmt":"2021-01-22T21:05:48","slug":"medical-parkta-diyabet-konusuldu","status":"publish","type":"post","link":"https:\/\/www.erzhaber.com.tr\/?p=1560780","title":{"rendered":"Med\u0131cal Park\u2019ta diyabet konu\u015fuldu"},"content":{"rendered":"<p><img decoding=\"async\" src=\"http:\/\/www.erzurumflas.com\/wp-content\/uploads\/2021\/01\/medical-parkta-diyabet-konusuldu_e1aca92.jpg\" width=\"600\">Medical Park Gaziantep Hastanesi Endokrinoloji ve Metabolizma Hastal\u0131klar\u0131 Uzman\u0131 Prof. Dr. Mesut \u00d6zkaya, Diyabetes mellitus (\u015feker hastal\u0131\u011f\u0131) hakk\u0131nda bilgi verdi.<\/p>\n<p>Gaziantep Medical Park Hastanesi Endokrinoloji ve Metabolizma Hastal\u0131klar\u0131 Uzman\u0131 Prof. Dr. Mesut \u00d6zkaya, Halk aras\u0131nda \u015feker hastal\u0131\u011f\u0131 olarak bilinen diyabetes mellitus di\u011fer bir ifade ile \u015feker hastal\u0131\u011f\u0131n\u0131n bug\u00fcn i\u00e7in toplumumuzda en \u00f6nemli halk sa\u011fl\u0131\u011f\u0131 sorunlar\u0131ndan biri oldu\u011funu belirtti. Diyabet hastal\u0131\u011f\u0131n\u0131n v\u00fccudumuzda kan \u015fekerini d\u00fc\u015f\u00fcrmeye yarayan ins\u00fclin hormonunun yoklu\u011fu ya da etkisizli\u011fine ba\u011fl\u0131 olarak ortaya \u00e7\u0131kt\u0131\u011f\u0131na vurgu yapan Prof. Dr. \u00d6zkaya \u015feker hastal\u0131\u011f\u0131n\u0131n t\u00fcm bedenimizi etkileyen metabolik bir hastal\u0131k oldu\u011funun alt\u0131n\u0131 \u00e7izdi.<\/p>\n<p>Diyabet hakk\u0131nda bilgiler veren Prof Dr. Mesut \u00d6zkaya, \u201cDiyabetes mellitusun 2 farkl\u0131 tipi vard\u0131r: Bunlardan birisi Tip 1 Diyabetes Mellitus\u2019dur. Tip 1 diyabetes mellitus, daha \u00e7ok gen\u00e7 ya\u015flarda g\u00f6r\u00fclen v\u00fccutta ins\u00fclin hormonunun yoklu\u011fu ile ortaya \u00e7\u0131kan hastal\u0131kt\u0131r. \u0130kinci diyabet tipi ise daha s\u0131k g\u00f6r\u00fclen tip 2 diyabetes mellitustur. Tip 2 diyabetes mellitusda ise sebep mevcut olan ins\u00fclin hormonunun etkisizli\u011fi t\u0131bbi ad\u0131yla ins\u00fclin direncidir. Diyabetes mellitus s\u0131k g\u00f6r\u00fclen bir hastal\u0131kt\u0131r. Son bilimsel \u00e7al\u0131\u015fmalara g\u00f6re \u00fclkemizde g\u00f6r\u00fclme oran\u0131 %13,7 olup bu oran b\u00f6lge ve \u015fehirlere g\u00f6re de\u011fi\u015fiklik g\u00f6stermektedir. \u00dclkemizde yakla\u015f\u0131k yedi ile on milyon kadar diyabet hastas\u0131n\u0131n oldu\u011fu tahmin edilmektedir. T\u00fcm diyabet hastalar\u0131n\u0131n yakla\u015f\u0131k y\u00fczde on &#8211; on be\u015fi tip 1 diyabetli iken geri kalan y\u00fczde seksen be\u015f &#8211;  doksan\u0131 tip 2 diyabetlidir. Diyabetin erken tan\u0131s\u0131 i\u00e7in bilinmesi gereken temel kurallar a\u015fa\u011f\u0131da yer almaktad\u0131r: 45 ya\u015f\u0131ndan b\u00fcy\u00fck her birey mutlaka a\u00e7l\u0131k kan \u015fekerini \u00f6l\u00e7t\u00fcrmeli ve \u015feker y\u00fckleme testi yapt\u0131rmal\u0131d\u0131r. 45 ya\u015f\u0131ndan k\u00fc\u00e7\u00fck olan bireylerde ise a\u015fa\u011f\u0131daki \u00f6zelliklerden herhangi birisi varsa ya\u015f\u0131 ne olursa olsun mutlaka a\u00e7l\u0131k kan \u015fekerini \u00f6l\u00e7t\u00fcrmeli ve \u015feker y\u00fckleme testi yapt\u0131rmal\u0131d\u0131r. Kilo fazlal\u0131\u011f\u0131 olanlar, Tansiyon y\u00fcksekli\u011fi tespit edilenler ya da bu sebeple ila\u00e7 kullananlar, Kolesterol ya da trigliserid y\u00fcksekli\u011fi saptananlar yada bu sebeplerden dolay\u0131 ila\u00e7 kullananlar, Ailesinde birinci derece akrabalar\u0131n\u0131n herhangi birinde ( anne ,baba, karde\u015f, amca, hala, day\u0131, teyze) \u015feker hastal\u0131\u011f\u0131 olanlar, Daha \u00f6nceki gebeli\u011finde iri bebek ( d\u00f6rt kilogram\u0131n \u00fcst\u00fc) do\u011furanlar, Daha \u00f6nceki gebeliklerinde gebeli\u011fe ba\u011fl\u0131 \u015feker hastal\u0131\u011f\u0131 tespit edilenler, Daha \u00f6nce \u00f6l\u00e7\u00fclen a\u00e7l\u0131k kan \u015fekeri 100 ile 126 aras\u0131nda \u00e7\u0131kanlar, Daha \u00f6nce \u00f6l\u00e7\u00fclen tokluk kan \u015fekeri 140 ile 200 aras\u0131nda \u00e7\u0131kanlar, Polikistik over hastal\u0131\u011f\u0131 olanlar, Son zamanlarda \u00e7ok su i\u00e7en, \u00e7ok idrara giden, halsizli\u011fi ve zay\u0131flamas\u0131 olanlar, Herhangi bir sebeple yap\u0131lan idrar tahlilinde \u015feker saptananlar. Bu \u00f6zelliklerden herhangi birine sahip olan ki\u015filerin mutlaka diyabet hastal\u0131\u011f\u0131 y\u00f6n\u00fcnden tetkik edilip de\u011ferlendirilmesi gerekir. Bu gibi durumlarda diyabet hastal\u0131\u011f\u0131 \u015f\u00fcphe edilen aday ki\u015filere \u015feker y\u00fckleme testi yap\u0131larak durum kolayl\u0131kla ayd\u0131nlat\u0131l\u0131r. A\u00e7l\u0131k kan \u015fekerine g\u00f6re saptanamay\u0131p \u015feker y\u00fckleme testi sonras\u0131 diyabet tan\u0131s\u0131 alan ki\u015filere de halk aras\u0131nda s\u00f6ylenen \u2018gizli \u015feker\u2019 tan\u0131s\u0131 konmu\u015f olur\u2019\u2019 dedi.<\/p>\n<p>Diyabet belirtileri<\/p>\n<p>Prof. Dr. \u00d6zkaya, Diyabet hastal\u0131\u011f\u0131n\u0131n erkenden tan\u0131s\u0131 konulabilen bir hastal\u0131k oldu\u011funu ifade ederek, Erken tan\u0131da bireylerin baz\u0131 \u015fikayetlerinin \u00f6nemli bir yol g\u00f6sterici oldu\u011funu kaydetti.<\/p>\n<p>Diyabet belirtilerine de\u011finen Prof. Dr. \u00d6zkaya, \u201cDiyabet hastalar\u0131nda olabilecek \u015fikayetlerin, \u00e7ok su i\u00e7me, \u00e7ok idrara gitme, halsizlik, yorgunluk, \u0130\u015ftah art\u0131\u015f\u0131na ra\u011fmen kilo kayb\u0131, s\u0131k mantar enfeksiyonu, a\u011f\u0131z ya da dil damak kurumas\u0131, yemeklerden yakla\u015f\u0131k bir bu\u00e7uk iki saat sonra olan uyuklama, terleme, i\u00e7 ge\u00e7mesi gibi \u015feker d\u00fc\u015fmesi \u015fikayetlerinin olmas\u0131 ba\u015fl\u0131ca belirtilerdir. Diyabet hastal\u0131\u011f\u0131 tan\u0131s\u0131n\u0131n konulabilmesi i\u00e7in, on-on iki saatlik a\u00e7l\u0131k sonras\u0131 \u00f6l\u00e7\u00fclen kan \u015fekerinin 126 mgr\/dl ve \u00fczerinde olmas\u0131, herhangi bir zamanda rastgele \u00f6l\u00e7\u00fclen kan \u015fekerinin 200 mgr\/dl ve \u00fczerinde olmas\u0131, do\u011fru \u015fartlarda ve kural\u0131na uygun yap\u0131lan \u015feker y\u00fckleme testinde 2. Saat kan \u015fekerinin 200 mgr\/dl\u2019nin \u00fczerinde olmas\u0131, \u00dc\u00e7 ayl\u0131k \u015feker ortalamas\u0131n\u0131 g\u00f6steren hemoglobin A1c nin y\u00fczde 6.5 ve \u00fczerinde olmas\u0131 gibi g\u00f6stergelerin olmas\u0131 yeterlidir\u201d ifadelerini kulland\u0131.<\/p>\n<p>Diyabet tedavisi<\/p>\n<p>Diyabet tedavisine hakk\u0131nda bilgilendirme yapan Prof. Dr. Mesut \u00d6zkaya, \u201cDiyabet hastalar\u0131nda tan\u0131 konulduktan sonra ya da diyabet tan\u0131s\u0131 olan bir hastada \u00f6nemli noktalardan birisi de do\u011fru takip ve tedavidir. Tedaviden sadece ila\u00e7 ya da ins\u00fclin tedavisinin anla\u015f\u0131lmamas\u0131 gerekir. Diyabetik bir hastan\u0131n tedavi kurallar\u0131, diyabetik hastan\u0131n e\u011fitimi, ki\u015fiye \u00f6zg\u00fc t\u0131bbi beslenme tedavisi, ki\u015fiye \u00f6zg\u00fc egzersiz \/ fiziksek aktivite, ila\u00e7 tedavisi olarak \u00f6ne \u00e7\u0131kmaktad\u0131r. Bug\u00fcn i\u00e7in diyabet tedavisinde kullan\u0131lan pek \u00e7ok a\u011f\u0131z yoluyla kullan\u0131lan ila\u00e7lar ve ins\u00fclin tedavisi yer almaktad\u0131r. Tip 1 diyabetik hastalarda ila\u00e7 tedavisi olarak sadece ins\u00fclin kullan\u0131l\u0131rken, tip 2 diyabetik hastalarda ise pek \u00e7ok \u00e7e\u015fitli ila\u00e7lar ve ins\u00fclin se\u00e7enekleri vard\u0131r. Diyabetik bir hasta hangi tip olursa olsun uygulanan tedavinin baz\u0131 hedefleri vard\u0131r. Tedavi hedefleri \u015fu \u015fekilde s\u0131ralanabilinir. a\u00e7l\u0131k kan \u015fekeri, 110 mgr\/dl \u2018nin alt\u0131, 2. saat tokluk kan \u015fekeri: 140 mgr\/dl\u2019nin alt\u0131, 3 ayl\u0131k \u015feker ortalamas\u0131n\u0131 g\u00f6steren HbA1c de\u011ferinin %7\u2019nin alt\u0131nda olmas\u0131, ancak baz\u0131 \u00f6zel durumlarda bu hedeflerin daha y\u00fcksek de\u011ferlerde kabul edilebilece\u011fini unutmamak gerekir. Diyabet hastalar\u0131nda tedavinin amac\u0131 sadece yukardaki rakamsal hedefleri yakalamak de\u011fildir. As\u0131l ama\u00e7 diyabetin sebep oldu\u011fu olumsuz sonu\u00e7lar\u0131 engellemektir. \u00c7\u00fcnk\u00fc diyabet tedavisi tam yap\u0131lmazsa ya\u015fam s\u00fcresini ne yaz\u0131k ki k\u0131saltan bir hastal\u0131kt\u0131r. Ayr\u0131ca sadece diyabet ya\u015fam s\u00fcresini k\u0131saltmakla kalmaz beraberinde insan\u0131n ya\u015fam kalitesini bozan pek \u00e7ok sa\u011fl\u0131k sorununa neden olmaktad\u0131r. Bug\u00fcn i\u00e7in diyabet hastalar\u0131nda en \u00f6nemli \u00f6l\u00fcm sebebi kalp krizi gibi v\u00fccuttaki damarlar\u0131 i\u00e7eren hastal\u0131klard\u0131r. Yine diyabet hastal\u0131\u011f\u0131 g\u00fcn\u00fcm\u00fczde k\u00f6rl\u00fc\u011f\u00fcn, diyalize girecek kadar ilerleyen b\u00f6brek yetmezli\u011finin ve kazalar hari\u00e7 ayak kesilmelerinin en \u00f6nemli sebebidir. S\u0131k g\u00f6r\u00fclmesine ra\u011fmen diyabetten korkmadan bilin\u00e7li toplum d\u00fc\u015f\u00fcncesiyle m\u00fccadele edilmesi tedavi ve sonu\u00e7lar\u0131n iyi sonu\u00e7lar\u0131n\u0131n anahtar\u0131 olacakt\u0131r. Diyabet hayata tatl\u0131 bir bak\u0131\u015ft\u0131r\u201d diye konu\u015ftu.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MED\u0130CAL PARK GAZ\u0130ANTEP HASTANES\u0130 ENDOKR\u0130NOLOJ\u0130 VE METABOL\u0130ZMA HASTALIKLARI UZMANI PROF. DR. MESUT \u00d6ZKAYA<\/p>\n","protected":false},"author":1,"featured_media":1560781,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,20],"tags":[2359,15055,14659,15461],"class_list":["post-1560780","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","category-turkiye","tag-diyabet","tag-konusuldu","tag-medical","tag-parkta"],"_links":{"self":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/1560780","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1560780"}],"version-history":[{"count":0,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/1560780\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/media\/1560781"}],"wp:attachment":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1560780"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1560780"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1560780"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}